Home » Stocks » BIOT

Biotech Acquisition Company (BIOT)

Biotech Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Market Cap 250.00M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 25.00M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Hide News
NASDAQ - 2 weeks ago

Biotech Acquisition Company, a blank check company formed by CRO and venture investor SPRIM targeting the biotech industry, filed on Thursday with the SEC for an initial public offering.

SEC - 2 weeks ago

Biotech Acquisition Company has filed to go public with an IPO on the NASDAQ.

About BIOT

Biotech Acquisition is a recently organized blank check company incorporated as a Cayman Islands exempted company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one business. We intend to focus on industries that complement our sponsor and management team’s background as affiliates of SPRIM Global Investments, a leading life science investment firm in the healthcare industry. As such, our target sector is expected to be the healthcare... [Read more...]

Industry
Blank Checks / SPAC
IPO Date
Pending
CEO
Michael Shleifer
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
BIOT
Full Company Profile